Recent trends in the stock market have provided investor optimism, with many experts forecasting a robust performance in 2026. Despite the substantial gains witnessed in 2025, certain stocks remain overlooked, presenting new investment opportunities for discerning investors.
Among the notable underperformers from last year is Rightmove, the UK’s largest property search portal. This company, noted for its industry dominance and previous takeover interest, is currently trading at an attractive valuation, making it a candidate for potential recovery. Other companies that struggled include Sage, RELX, Marks and Spencer, Diageo, and London Stock Exchange Group. Each of these entities has seen their share prices significantly fall from previous highs, prompting a closer inspection for possible rebounds.
The healthcare sector, which largely missed out on the market rally last year, is showing signs of stabilization. As investors increasingly seek to diversify their portfolios beyond technology, healthcare stocks could emerge as a favorable choice. The sector stands to benefit from demographic shifts, particularly with an aging population, alongside innovative developments such as new weight-loss medications, which could enhance growth prospects. However, investing directly in individual healthcare stocks carries risks, including the potential for failed drug trials or regulatory challenges. For those looking to mitigate risk while still gaining exposure to the sector, healthcare exchange-traded funds (ETFs) can provide access to a broad range of stocks.
Additionally, the concept of “Warren Buffett-type” investments, characterized by companies with economic moats, steady revenues, and strong profitability, warrants attention. These “quality” stocks, which had been overshadowed in the previous year by investor interest in cyclical sectors like banking, are predicted to perform better in the upcoming year. In times of market volatility, these stocks could offer a more stable investment option.
One noteworthy candidate in this space is Automatic Data Processing (NASDAQ: ADP), recognized as the world’s leading payroll service provider. Its business model boasts resilient, recurring revenue, given the challenges firms face when switching payroll services. Furthermore, ADP demonstrates high profitability, with a return on capital averaging over 40% over the past five years. The company has also established a solid track record of dividend increases, having raised its payouts for 51 consecutive years. Currently, its price-to-earnings ratio sits in the low 20s, potentially making it an appealing buy.
While considerations such as the impact of artificial intelligence present risks, the overall outlook for these stocks appears promising. As 2026 approaches, the strategies of focusing on undervalued equities, exploring the healthcare sector, and considering long-term quality investments may present valuable opportunities for investors navigating a dynamic market.
